Alnylam Pharmaceuticals, Inc. (ALNY)

327.25 -5.60 (-1.68%) USD  |  NASDAQ  |  Feb 25, 16:00
327.25 0.00 (0.00%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Return on Equity (3y Mean)

Return on Equity (3y Mean) Chart

View Return on Equity (3y Mean) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Equity (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Equity (3y Mean) Range, Past 5 Years

View Return on Equity (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Equity (3y Mean) Benchmarks

View Return on Equity (3y Mean) Benchmarks
Start Trial
Insmed, Inc. --
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade